151 – 200 of 271
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.
(
- Contribution to journal › Scientific review
-
Mark
Molecular coagulation and thrombophilia.
2005) p.158-158(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The importance of the protein C system in the pathogenesis of venous thrombosis.
(
- Contribution to journal › Article
- 2004
-
Mark
Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H.
(
- Contribution to journal › Article
-
Mark
Anticoagulant factor V and thrombosis risk
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells.
(
- Contribution to journal › Article
-
Mark
Progress in the understanding of the protein C anticoagulant pathway.
(
- Contribution to journal › Article
-
Mark
Functional properties of recombinant factor V mutated in a potential calcium-binding site.
(
- Contribution to journal › Article
-
Mark
Ligand recognition and homophilic interactions in Tyro3 - Structural insights into the Axl/Tyro3 receptor tyrosine kinase family
(
- Contribution to journal › Article
-
Mark
Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1.
(
- Contribution to journal › Article
-
Mark
Altered inactivation pathway of factor Va by activated protein C in the presence of heparin
(
- Contribution to journal › Article
-
Mark
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?
(
- Contribution to journal › Scientific review
-
Mark
Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts.
(
- Contribution to journal › Article
-
Mark
Functions of human complement inhibitor C4b-binding protein in relation to its structure.
(
- Contribution to journal › Scientific review
-
Mark
Functional characterization of Factor V-Ile359Thr, a novel mutation associated with thrombosis.
(
- Contribution to journal › Article
-
Mark
The multiple faces of the partial thromboplastin time APTT.
(
- Contribution to journal › Letter
-
Mark
Characterization of apoM in normal and genetically modified mice
(
- Contribution to journal › Article
-
Mark
Enhanced rate of cleavage at Arg306 and Arg506 in coagulation factor Va by Gla domain-mutated human activated protein C.
(
- Contribution to journal › Article
-
Mark
Identification of the MMRN1 binding region within the C2 domain of human factor V
(
- Contribution to journal › Article
- 2003
-
Mark
Gla-domain mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding.
(
- Contribution to journal › Article
-
Mark
Factor VI359T: a novel mutation associated with thrombosis and resistance to activated protein C
(
- Contribution to journal › Article
-
Mark
Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
(
- Contribution to journal › Article
-
Mark
The discovery of activated protein C resistance.
(
- Contribution to journal › Article
-
Mark
Molecular recognition in the protein C anticoagulant pathway.
(
- Contribution to journal › Article
-
Mark
Successful hunt for quantitative trait locus in thrombophilia
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis dependent.
(
- Contribution to journal › Article
-
Mark
Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma.
(
- Contribution to journal › Article
-
Mark
Congenital and acquired activated protein C resistance.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein (C4BP) activates B cells through the CD40 receptor
(
- Contribution to journal › Article
-
Mark
CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
(
- Contribution to journal › Article
-
Mark
Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women.
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance (FVLeiden) and thrombosis: factor V mutations causing hypercoagulable states
(
- Contribution to journal › Scientific review
-
Mark
Diagnosing protein S deficiency: analytical considerations.
(
- Contribution to journal › Article
-
Mark
Factor V Leiden in pregnancies complicated by placental abruption
(
- Contribution to journal › Article
-
Mark
Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S.
(
- Contribution to journal › Article
-
Mark
Role of CCP2 of the C4b-binding protein beta-chain in protein S binding evaluated by mutagenesis and monoclonal antibodies.
(
- Contribution to journal › Article
-
Mark
Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
(
- Contribution to journal › Article
-
Mark
Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
(
- Contribution to journal › Article
-
Mark
Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.
(
- Contribution to journal › Article
- 2002
-
Mark
Functional characterization of recombinant FV Hong Kong and FV Cambridge.
(
- Contribution to journal › Article
-
Mark
Structural requirements of anticoagulant protein S for its binding to the complement regulator c4b-binding protein
(
- Contribution to journal › Article
-
Mark
Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site.
(
- Contribution to journal › Article
-
Mark
Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype.
(
- Contribution to journal › Article
-
Mark
Rapid intracellular degradation of a truncated mutant protein S (Q522X)
(
- Contribution to journal › Letter
-
Mark
Individual risk assessment of thrombosis in pregnancy.
(
- Contribution to journal › Article
-
Mark
Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S
(
- Contribution to journal › Article
-
Mark
Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.
(
- Contribution to journal › Article
-
Mark
Vitamin k-dependent protein s localizing complement regulator c4b-binding protein to the surface of apoptotic cells.
(
- Contribution to journal › Article
-
Mark
Genetic and phenotypic variability between families with hereditary protein S deficiency
(
- Contribution to journal › Article
-
Mark
Factor V Leiden and the genetics of myocardial infarction: we need to look elsewhere.
(
- Contribution to journal › Article